Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 Products In The Liraglutide Market

"What Are the Projections for the Size and Growth Rate of the Liraglutide Market?
The market for liraglutide has seen robust expansion in the past few years. The market is projected to escalate from $6.38 billion in 2024 to $6.95 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This surge during the historic period can be linked to the rising numbers of individuals being identified with type 2 diabetes, mounting obesity rates, widespread clinical research, increased understanding of ramifications associated with diabetes, and emerging advancements in drug delivery mechanisms.

The market size for liraglutide is projected to witness considerable expansion in the upcoming years, surging to a value of $9.66 billion in 2029, with a compound annual growth rate (CAGR) at 8.6%. The anticipated growth throughout this forecast period can be linked to factors such as the rise in insurance and reimbursement policies, advancements in healthcare facilities, heightened awareness and educational endeavours, an increasing elderly population, and the growing occurrence of diabetes. Leading trends expected to be seen during this forecast period involve the application of artificial intelligence and machine learning, the demand for wearable technology, integration of continuous glucose monitoring, progress in biotechnology, and the evolution of digital health platforms.

What Are the Primary Growth Drivers for the Liraglutide Market?
The escalation in the number of diabetic individuals is anticipated to fuel the expansion of the liraglutide market. Diabetes, a persistent ailment where the body struggles to regulate blood sugar levels due to inadequate insulin production or ineffective utilization of insulin, is growing due to factors such as inactive lifestyles, poor diet regimen, and mounting obesity levels globally. Medications for diabetes, like liraglutide, work by replicating the function of the hormone GLP-1, amplifying insulin release, diminishing blood sugar, and fostering weight reduction, thereby assisting in the control of type 2 diabetes. For instance, a report by the UK Government on a UK-based information website in March 2024 stated, in March 2023, the percentage of type 1 diabetes patients in England receiving all 8 care processes at GP practices part of the NDA had escalated to 43.8%, compared to 35.2% the previous year. Consequently, the growing diabetic demographic is propelling the liraglutide market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

Which Businesses Are at the Forefront of Liraglutide Market Development?
Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

What Are the Latest Innovations in the Liraglutide Market?
Leading firms in the liraglutide market are innovating new products like generic GLP-1 in order to broaden the range of treatment choices and cater to the market need for less expensive options. Generic GLP-1 is a term applied to GLP-1 receptor agonists variants that are manufactured following the termination of patent rights on the initial branded drugs, providing affordable substitutes for treating diseases such as type 2 diabetes and obesity. For example, in June 2024, the Israel-based pharmaceutical company, Teva Pharmaceutical Industries Ltd., launched the first generic GLP-1, akin to Victoza, in the U.S. market, satisfying the growing need for these types of treatments. Liraglutide injections are recommended to improve blood sugar regulation in adults and children who are 10 years old or above with type 2 diabetes and to decrease the possibility of cardiovascular events in adults suffering from type 2 diabetes and established cardiovascular diseases.

How Is the Liraglutide Market Segmented?
The liraglutide market covered in this report is segmented -

1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:
1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Where Is the Liraglutide Market Growth Most Prominent?
North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Liraglutide Global Market Report?

- Market Size Analysis: Analyze the Liraglutide Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Liraglutide Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Liraglutide Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Liraglutide Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18659

"

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.